Xing Song

AI
h-index20
3papers
55citations
Novelty17%
AI Score35

3 Papers

6.4AIApr 28
TrialCalibre: A Fully Automated Causal Engine for RCT Benchmarking and Observational Trial Calibration

Amir Habibdoust, Xing Song

Real-world evidence (RWE) studies that emulate target trials increasingly inform regulatory and clinical decisions, yet residual, hard-to-quantify biases still limit their credibility. The recently proposed BenchExCal framework addresses this challenge via a two-stage Benchmark, Expand, Calibrate process, which first compares an observational emulation against an existing randomized controlled trial (RCT), then uses observed divergence to calibrate a second emulation for a new indication causal effect estimation. While methodologically powerful, BenchExCal is resource intensive and difficult to scale. We introduce TrialCalibre, a conceptualized multiagent system designed to automate and scale the BenchExCal workflow. Our framework features specialized agents such as the Orchestrator, Protocol Design, Data Synthesis, Clinical Validation, and Quantitative Calibration Agents that coordi-nate the the overall process. TrialCalibre incorpo-rates agent learning (e.g., RLHF) and knowledge blackboards to support adaptive, auditable, and transparent causal effect estimation.

5.8AIAug 31, 2025
Causal MAS: A Survey of Large Language Model Architectures for Discovery and Effect Estimation

Adib Bazgir, Amir Habibdoust, Yuwen Zhang et al.

Large Language Models (LLMs) have demonstrated remarkable capabilities in various reasoning and generation tasks. However, their proficiency in complex causal reasoning, discovery, and estimation remains an area of active development, often hindered by issues like hallucination, reliance on spurious correlations, and difficulties in handling nuanced, domain-specific, or personalized causal relationships. Multi-agent systems, leveraging the collaborative or specialized abilities of multiple LLM-based agents, are emerging as a powerful paradigm to address these limitations. This review paper explores the burgeoning field of causal multi-agent LLMs. We examine how these systems are designed to tackle different facets of causality, including causal reasoning and counterfactual analysis, causal discovery from data, and the estimation of causal effects. We delve into the diverse architectural patterns and interaction protocols employed, from pipeline-based processing and debate frameworks to simulation environments and iterative refinement loops. Furthermore, we discuss the evaluation methodologies, benchmarks, and diverse application domains where causal multi-agent LLMs are making an impact, including scientific discovery, healthcare, fact-checking, and personalized systems. Finally, we highlight the persistent challenges, open research questions, and promising future directions in this synergistic field, aiming to provide a comprehensive overview of its current state and potential trajectory.

1.1CLJul 13, 2020
COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model

Jingqi Wang, Noor Abu-el-rub, Josh Gray et al.

The COVID-19 pandemic swept across the world rapidly, infecting millions of people. An efficient tool that can accurately recognize important clinical concepts of COVID-19 from free text in electronic health records (EHRs) will be valuable to accelerate COVID-19 clinical research. To this end, this study aims at adapting the existing CLAMP natural language processing tool to quickly build COVID-19 SignSym, which can extract COVID-19 signs/symptoms and their 8 attributes (body location, severity, temporal expression, subject, condition, uncertainty, negation, and course) from clinical text. The extracted information is also mapped to standard concepts in the Observational Medical Outcomes Partnership common data model. A hybrid approach of combining deep learning-based models, curated lexicons, and pattern-based rules was applied to quickly build the COVID-19 SignSym from CLAMP, with optimized performance. Our extensive evaluation using 3 external sites with clinical notes of COVID-19 patients, as well as the online medical dialogues of COVID-19, shows COVID-19 Sign-Sym can achieve high performance across data sources. The workflow used for this study can be generalized to other use cases, where existing clinical natural language processing tools need to be customized for specific information needs within a short time. COVID-19 SignSym is freely accessible to the research community as a downloadable package (https://clamp.uth.edu/covid/nlp.php) and has been used by 16 healthcare organizations to support clinical research of COVID-19.